“…9 By virtue of its high binding affinity toward the cell surface FR, which is overexpressed in a number of pathologic cells, selective delivery of nonspecific drugs that are conjugated to folate can be achieved. Derivatization of folate has been successfully exploited in the targeted delivery of proteins, 10,11 liposomes, 12 DNA nanoparticles, 13,14 synthetic organic 15,16 and inorganic nanoparticles, 17,18 and polymers. 19 As a targeting ligand, folate has many important advantages compared to monoclonal antibodies, such as low immunogenicity, high specificity, and resistance to denaturation, etc.…”